January 11, 2021 — Medtronic has received a new expanded indication from Health Canada for its Evolut Transcatheter Aortic Valve Implantation (TAVI) system. Medtronic's TAVI platform is currently the only system licensed for both bicuspid aortic valves (intermediate or greater risk), as well as all surgical risk categories in Canada.
